Picture of Regeneron Pharmaceuticals logo

REGN — Regeneron Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Regeneron Pharmaceuticals Said Single Administration Of CIDEB(siRNA) Led To Reductions In Liver Fat Up To 80% That Were Sustained Through 36 Weeks

BRIEF-Regeneron Pharmaceuticals Said Single Administration Of CIDEB(siRNA) Led To Reductions In Liver Fat Up To 80% That Were Sustained Through 36 Weeks

- Regeneron Pharmaceuticals, Inc. REGN.O:

  • REGENERON PHARMACEUTICALS, INC.: SINGLE ADMINISTRATION OF CIDEB(SIRNA) LED TO REDUCTIONS IN LIVER FAT UP TO 80% THAT WERE SUSTAINED THROUGH 36 WEEKS

Further company coverage: REGN.O


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Regeneron Pharmaceuticals

See all news